Medicine Requirements and Budget Implication for Pediatric Acute Lymphoblastic Leukemia in Indonesia: A Morbidity-Based Approach
Dita N S Argadiredja, Mohammed Alfaqeeh, Yasmin Fatinah, Vesara Ardhe Gatera, Lucia R Andalusia, Rano K Sinuraya, Dina Abushanab, Rizky Abdulah, Auliya A Suwantika · 2026
Read Medicine Requirements and Budget Implication for Pediatric Acute Lymphoblastic Leukemia in Indonesia: A Morbidity-Based Approach by Dita N S Argadiredja, Mohammed Alfaqeeh, Yasmin Fatinah, Vesara Ardhe Gatera, Lucia R Andalusia, Rano K Sinuraya, Dina Abushanab, Rizky Abdulah, Auliya A Suwantika (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13546040.txt.
Description
Dita Argadiredja and co-authors estimate drug needs and budgets for childhood leukemia in Indonesia in work from 2026. Limited supply, high cost, and reliance on imports hinder care, and national quantity data were lacking.
Using records from three referral hospitals plus registry and guideline data, the team modeled needs by disease rates. Standard-risk and high-risk care together came to a modest national drug budget, with one drug, L-asparaginase, taking the largest share. The first treatment phase cost the most. The model assumed full standard courses with no breaks or dose changes.
Catalog record
| CREATOR | Dita N S Argadiredja, Mohammed Alfaqeeh, Yasmin Fatinah, Vesara Ardhe Gatera, Lucia R Andalusia, Rano K Sinuraya, Dina Abushanab, Rizky Abdulah, Auliya A Suwantika |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |